Analyst Ratings For Portola Pharmaceuticals (NASDAQ:PTLA)
Today, Oppenheimer Holdings, Inc. raised its price target on Portola Pharmaceuticals (NASDAQ:PTLA) to $80.00 per share.
There are 2 hold ratings, 6 buy ratings on the stock.
The current consensus rating on Portola Pharmaceuticals (NASDAQ:PTLA) is Buy (Score: 2.75) with a consensus target price of $63.83 per share, a potential 3.34% downside.
Some recent analyst ratings include
- 6/26/2017-Credit Suisse Group Reiterated Rating of Neutral.
- 6/26/2017-William Blair Reiterated Rating of Outperform.
- 2/24/2017-CIBC Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
Recent Insider Trading Activity For Portola Pharmaceuticals (NASDAQ:PTLA)
Portola Pharmaceuticals (NASDAQ:PTLA) has insider ownership of 4.90% and institutional ownership of 84.97%.
- On 7/18/2017 John T. Curnutte, Insider, sold 10,000 with an average share price of $65.00 per share and the total transaction amounting to $650,000.00. View SEC Filing
- On 7/18/2017 Tao Fu, EVP, sold 5,812 with an average share price of $65.00 per share and the total transaction amounting to $377,780.00. View SEC Filing
- On 7/11/2017 Mardi Dier, VP, sold 23,350 with an average share price of $60.00 per share and the total transaction amounting to $1,401,000.00. View SEC Filing
- On 6/28/2017 William Lis, CEO, sold 269,299 with an average share price of $55.43 per share and the total transaction amounting to $14,927,243.57. View SEC Filing
- On 6/27/2017 Mardi Dier, VP, sold 93,392 with an average share price of $55.46 per share and the total transaction amounting to $5,179,520.32. View SEC Filing
- On 6/26/2017 John T. Curnutte, Insider, sold 60,000 with an average share price of $57.88 per share and the total transaction amounting to $3,472,800.00. View SEC Filing
- On 6/26/2017 Tao Fu, EVP, sold 7,000 with an average share price of $57.14 per share and the total transaction amounting to $399,980.00. View SEC Filing
Recent Trading Activity for Portola Pharmaceuticals (NASDAQ:PTLA)
Shares of Portola Pharmaceuticals closed the previous trading session at 66.04 up +0.75 1.15% with 1,024,717 shares trading hands.